Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
DOI: https://doi.org/10.2478/ahem-2021-0037 | Journal eISSN: 1732-2693
Language: English
Page range: 16 - 23
Submitted on: Jan 1, 2021
Accepted on: Jul 16, 2021
Published on: Feb 20, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2022 Łukasz Bułdak, Estera Skudrzyk, Grzegorz Machnik, Aleksandra Bołdys, Rafał Jakub Bułdak, Bogusław Okopień, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.